During the COVID-19 pandemic, we saw warp-speed development of vaccines in some parts of the world. But for Africa, the pandemic highlighted the urgent need to build capacity on the continent to develop and manufacture much-needed vaccines. This is something the African Vaccine Manufacturing Initiative (AVMI) has been advocating for over 10 years. In a wide-ranging interview with WIPO Magazine, AVMI Executive Director and co-founder Patrick Tippoo, who is also Head of Science and Innovation at the South African bio-pharmaceutical company, Biovac, explains why vaccine independence for Africa is so important.
展开▼